Generica India Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 16-07-2024
- Paid Up Capital ₹ 1.01 Cr
as on 16-07-2024
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.70 M
as on 16-07-2024
- Satisfied Charges ₹ 4.70 M
as on 16-07-2024
- Revenue 9.26%
(FY 2023)
- Profit -10.19%
(FY 2023)
- Ebitda -9.83%
(FY 2023)
- Net Worth 12.28%
(FY 2023)
- Total Assets 9.45%
(FY 2023)
About Generica India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.01 Cr.
The company currently has active open charges totaling ₹2.70 M. The company has closed loans amounting to ₹4.70 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Mediratta, Amit Mediratta, Hemraj Thakur, and One other member serve as directors at the Company.
- CIN/LLPIN
U52311DL1999PLC099819
- Company No.
099819
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 May 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Narela, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Generica India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Mediratta  | Managing Director | 19-May-1999 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Mediratta | Whole-Time Director | 01-Dec-2001 | Current |
| Hemraj Thakur | Director | 20-Jun-2016 | Current |
| Arun Khanna | Director | 17-Nov-2021 | Current |
Financial Performance of Generica India.
Generica India Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.26% increase. The company also saw a substantial fall in profitability, with a 10.19% decrease in profit. The company's net worth Soared by an impressive increase of 12.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Generica India?
In 2023, Generica India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Veritas Life Sciences LimitedActive 19 years 2 months
Anil Mediratta and Amit Mediratta are mutual person
- Pharmasys Private LimitedActive 5 years 7 months
Anil Mediratta and Amit Mediratta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Sep 2023 | ₹2.70 M | Open |
Central Bank Of India Creation Date: 16 Oct 2002 | ₹4.70 M | Satisfied |
How Many Employees Work at Generica India?
Generica India has a workforce of 74 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Generica India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Generica India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
